Project Grant DP2AI184733
Award Date
8/15/24
Completion Date
7/31/29
Dollars Obligated
$483K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44106, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $700,350 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Case Western Reserve University (CWRU) to define the neovaginal microbiome in transgender women who have undergone or are scheduled to undergo gender-affirming vaginoplasty. The study aims to investigate associations between the neovaginal microbiome, genital inflammation, and clinical outcomes, including gynecological symptoms. This...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $300,000 to Topaz Biosciences, Inc. to discover and optimize novel endolysins that can selectively target Gardnerella vaginalis, a key bacterium associated with bacterial vaginosis (BV). The goal is to develop endolysins - phage-encoded enzymes that can degrade bacterial cell walls - that are more active, thermostable,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $196,452.00 to investigate the influence of the cervicovaginal phageome (bacteriophages) on the health and disease of women living with HIV. The project aims to determine how phageome communities contribute to regulating the female reproductive tract (FRT) bacterial populations and identify predictive biomarkers of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $152,216 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Pittsburgh to study anti-fungal immune responses in the female reproductive tract. The research aims to determine the cellular and molecular mechanisms by which type 3 cytokine signaling orchestrates immune control of vulvovaginal candidiasis (VVC), a prevalent and burdensome fungal infection affecting over 75% of...
This federal Project Grant award, valued at $148,568.00 and provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to elucidate the role of Akkermansia muciniphila in Group B Streptococcus (GBS) vaginal colonization and ascending infection. The award supports research to investigate the specific mechanisms by which A. muciniphila promotes GBS adherence to human vaginal epithelial cells,...
This federal Project Grant award, provided by the National Institute of Child Health and Human Development (NICHD) under CFDA Program 93.865 - Child Health and Human Development Extramural Research, aims to determine the effects of bacterial vaginosis on inflammatory macrophage activation and its impact on HIV risk. The $533,750 project will be conducted by the University of Florida over a 5-year period from September 1, 2024 to July 31, 2029. The key research activities under this grant...
This $184,528 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to define the associations between antibody-bound and unbound vaginal bacterial populations and their functions in women with or without human papillomavirus (HPV) infection and different stages of cervical pathology. The grantee, Case Western Reserve University, will utilize an existing observational cohort to sort vaginal bacterial cells into...
This $226,204 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to identify specific features of the vaginal microbiome and immune responses that contribute to spontaneous clearance of Chlamydia trachomatis (CT) infection. The project will leverage a unique longitudinal dataset of cervicovaginal samples to evaluate whether bacterial growth rates, Th1 and Th17...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $873,600.00 to the University of Colorado-Denver over 24 months to conduct research on the role of commensal bacteria in promoting mucosal colonization by Group B Streptococcus (GBS). The research aims to: 1) determine the mechanism by which the commensal bacterium Akkermansia muciniphila increases GBS...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $883,497 to the University of Pittsburgh to conduct research on mucosal immunity and host defense against vaginal candidiasis. The research aims to improve understanding of the role of the Th17 pathway and other cytokines in promoting immunity to this widespread fungal infection. Key objectives include...